Dextran plasma expander with apparent volume expanding properties and antiplatelet action. Rheopolyglucin is prescribed for treatment of the retina and optic nerve deceases (complicated myopia, macular degeneration, etc.), inflammatory processes in cornea and choroid using its ability to reduce blood viscosity and restore blood flow to the small capillaries.